Toxicogenomics

1. Mechanistic toxicogenomics: Design and analysis of microarrayexperiments (Kirstin Meyer, Susanne Schwenke and Johanna M.Beekman).
2. Analysis and interpretation of toxicogenomic data: Biologicalresponses to low, environmentally-relevant doses of toxicants(Julia A. Gosse, Jennifer Davey, Thomas Hampton and JoshuaHamilton).
3. Principles of data-mining in toxicogenomics (Yoko Hirabayashiand Tohru Inoue).
4. Design issues in toxicogenomics studies: The application ofgenomic technologies for mechanistic and predictive research(Woong-Yang Park, Lian Li and Daehee Kang).
5. Sources of variability in toxicogenomic assays (KarolThompson, P. Scott Pine and Barry Rosenzweig).
6. Key aspects of toxicogenomic data analysis and interpretationas a safety assessment tool to identify and understand drug-inducedtoxicity (Antoaneta Vladimirova and Brigitte Ganter).
7. Toxicogenomics as a tool to assess immunotoxicity (KirstenBaken, J. Ezendam, J. Pennings, R. Vandebriel,and H. Loveren).
8. Toxicogenomics and ecogenomics for studying endocrinedisruption and basic biology (Taisen Iguchi, Hajime Watanabe andYoshino Kata).
9. Gene expression profiling of transplacental arseniccarcinogenesis in mice (Jie Liu, B. Diwan, R. Tennant and MichaelWaalkes).
10. Characterization of estrogen active compounds and estrogenicsignaling by global gene expression profiling in vitro (StephanieSimon, Kathleen Boehme, Susanne Schmidt and Stephan Mueller).
11. Escherichia coli stress response as a tool for detection oftoxicity (Arindam Mitra, Nabarun Chakraborti and SumanMukhopadhyay).
12. Toxicogenomics in vitro: A powerful tool for screeninghepatotoxic potential of food-related products (Saura C. Sahu).
13. Toxicogenomics approach to drug-induced phospholipidosis(Hiroshi Sawada).
14. Use of toxicogenomics as an early predictive tool forHepatotoxicity (Laura Suter).
15. Nutrigenomics: The application of genomic signatures innutrition-related research (Stamotis Theocharis and ElisavetGatzidou).
16. Application of toxicogenomics in drug discovery (MichaelLiguori, Amy Ditewig and Jeffery Waring).
17. Natural products from medicinal plants and risk assessment(Leila Chekir-Ghedira).
18. The development of a metabonomic-based drug safety testingparadigm (Muireann Coen, Elaine Holms, Jeremy Nicholson and JohnLindon).
19. Potential Uses of Toxicogenomic Biomarkers in OccupationalHealth and Risk Assessment (Paul A. Nony).
20. Usefulness of toxicogenomics in the regulatory environment(Daniel Casciano).
21. Toxicogenomics for regulatory use: the view from the bench(P. Ancian, S.Leuillett, S. Artaud, J. Jegard and Roy Forster).
22. Perspectives on toxicogenomics at the US EnvironmentalProtection Agency (Karen Hamernik, Kenneth Haymes, Susan Hester andThomas McClintock).